TG and metastatic neoplasm: The goal of this study was to evaluate whether the presence of TgAb influences the clinical sensitivity of Tg measured by different methodologies (IMA, MS, or RIA) in patients in whom a detectable serum Tg would be expected as a result of DTC with distant metastatic disease (DMD) (3) or hyperthyroidism (HY) (45).